Yutaka Yamamoto

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.7K citations · Full text

Chemotherapy Versus Placebo, Breast Oncology, Oncology +7

Creating an Optimal 3D Printed Model for Temporal Bone Dissection Training

Kuniyuki Takahashi, Yuka Morita, Shinsuke Ohshima et al. · Annals of Otology Rhinology & Laryngology · 2017 · 45 citations

Evaluation of Trastuzumab Without Chemotherapy as a Post-operative Adjuvant Therapy in HER2-positive Elderly Breast Cancer Patients: Randomized Controlled Trial [RESPECT (N-SAS BC07)]

Masataka Sawaki, Nahomi Tokudome, Toshiro Mizuno et al. · Japanese Journal of Clinical Oncology · 2011 · 40 citations · Full text

International Collaborative Assessment of the Validity of the EAONO-JOS Cholesteatoma Staging System

Adrian L. James, Tetsuya Tono, Michael S. Cohen et al. · Otology & Neurotology · 2019 · 34 citations · Full text

Surgical treatment of 52 cases of auditory ossicular malformations

Shigehisa Hashimoto, Yutaka Yamamoto, Hitoshi Satoh et al. · Auris Nasus Larynx · 2002 · 33 citations

Surgical Treatment, Audiology, Otolaryngology +5